The role of trophic factors and autocrine/paracrine growth factors in brain metastasis

Clinical & Experimental Metastasis

Volumn 13, Issue 2, 1995, Pages 67-88

  Menter, David G ^a   Herrmann, John L ^a   Nicolson, Garth L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

brain metastasis; growth factors; melanoma; melanotropins; nerve growth factor; neurotrophins; signal transduction; tumor progression; tyrosine receptor kinase

Indexed keywords

GROWTH FACTOR; NEUROTROPHIN; TRANSFERRIN;

AUTOCRINE EFFECT; BRAIN METASTASIS; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS POTENTIAL; MICROENVIRONMENT; REVIEW;

AMINO ACID SEQUENCE; ANIMAL; BASE SEQUENCE; BRAIN NEOPLASMS; CELL SURVIVAL; GROWTH SUBSTANCES; HUMAN; MELANOMA; MOLECULAR SEQUENCE DATA; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; RECEPTORS, NERVE GROWTH FACTOR; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028945672     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/BF00133612     Document Type: Article

References (140)

1. Metastasis to the central nervous system
2. Treatment of metastatic cancer to the brain
3. Characteristics of cultured human melanocytes isolated from different stages of tumor progression
4. Induction of growth factor RNA expression in human malignant melanoma: markers of transformation
5. Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis
6. Social controls on cell survival and cell death
7. The clonal evolution of tumor cells
8. Programmed cell death and the control of cell survival: lessons from the nervous system
9. Functions of the neurotrophins during nervous system development: what knockouts are teaching us
10. Nerve growth factor revisited
11. Ciliary neurotrophic factor and its receptor complex
12. Expression and structure of the human NGF receptor
13. Nerve growth factor induces protein-tyrosine phosphorylation
14. Nerve growth factor stimulates a protein kinase in PC-12 cells that phosphorylates microtubule-associated protein-2
15. Nerve growth factor stimulates the tyrosine phosphorylation of a 38-kDa protein that specifically associates with the src homology domain of phospholipase C-gamma 1
16. Neurotrophin receptors: a window into neuronal differentiation
17. The nerve growth factor family of receptors
18. Nerve growth factor: a tale of two receptors
19. Cellular mechanisms of signal transduction for neurotrophins
20. Neurotrophin 3 is a mitogen for cultured neural crest cells
21. Sympathetic neuroblasts undergo a developmental switch in trophic dependence
22. NT-3 stimulates sympathetic neuroblast proliferation by promoting precursor survival
23. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion
24. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents
25. Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements
26. Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death
27. Mice lacking brain-derived neurotrophic factor develop with sensory deficits
28. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development
29. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons
30. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene
31. Different neurotrophins are expressed and act in a developmental sequence to promote the survival of embryonic sensory neurons
32. Induction of nerve growth factor receptors in cultured human melanocytes
33. Human melanocyte growth and differentiation: a decade of new data
34. Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA
35. p75LNGFR regulates Trk signal transduction and NGF-induced neuronal differentiation in MAH cells
36. Induction of apoptosis by the low-affinity NGF receptor
37. Nerve growth factor suppresses apoptosis of murine neutrophils
38. Unraveling function in the TNF ligand and receptor families
39. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death
40. The p75 nerve growth factor receptor mediates survival or death depending on stage of sensory neuron development
41. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system
42. Dependence on p75 for innervation of some sympathetic targets
43. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor
44. Expression of functional nerve growth factor receptors after gene transfer
45. The low-affinity p75 nerve growth factor (NGF) receptor mediates NGF-induced tyrosine phosphorylation
46. Positive and negative effects of neurotrophins on the isthmo-optic nucleus in chick embryos
47. Molecular investigations on the high-affinity nerve growth factor receptor
48. Evidence that biological activity of NGF is mediated through a novel subclass of high affinity receptors
49. Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduces NGF binding to TrkA on PC12 cells
50. Identification of a conserved protein motif in a group of growth factor receptors
51. Neurotrophin induced CAMP and IP3 responses in PC 12 cells. Different pathways
52. Deletion of cytoplasmic sequences of the nerve growth factor receptor leads to loss of high affinity ligand binding
53. The low affinity NGF receptor, p75, can collaborate with each of the trks to potentiate functional responses to the neurotrophins
54. Nerve growth factor-activated protein kinase N. Characterization and rapid near homogeneity purification by nucleotide affinity-exchange chromatography
55. Association of a purine-analogue-sensitive protein kinase activity with p75 nerve growth factor receptors
56. Induction of ornithine decarboxylase by nerve growth factor in PC12 cells: dissection by purine analogues
57. Phospholipase C-gamma 1 directly associates with the p70 trk oncogene product through its src homology domains
58. Activation of phosphatidylinositol-3 kinase by nerve growth factor involves indirect coupling of the trk proto-oncogene with src homology 2 domains
59. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases
60. Tyrosine 785 is a major determinant of Trk-substrate interaction
61. Identification of Trk binding sites for SHC and phosphatidylinositol 3′-kinase and formation of a multimeric signaling complex
62. The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins
63. Growth factors differentially stimulate the phosphorylation of Shc proteins and their association with Grb2 in PC-12 pheochromocytoma cells
64. Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses
65. Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC gamma
66. Function of Ras as a molecular switch in signal transduction
67. Raf meets Ras: completing the signal transduction pathway
68. Nerve growth factor employs multiple pathways to induce primary response genes in PC12 cells
69. Isolation and characterization of a nerve growth factor-regulated Fos kinase from PC 12 cells
70. Ras-dependent growth factor regulation of MEK kinase in PC12 cells
71. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane
72. Activation of Raf as a result of recruitment to the plasma membrane
73. The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex
74. Association of protein kinases ERK1 and ERK2 with p75 nerve growth factor receptors
75. Nerve growth factor stimulates the activities of the raf-1 and the mitogen-activated protein kinases via the trk protooncogene
76. Activation of the sphyngomyelin cycle through the low-affinity neurotrophin receptor
77. Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction
78. Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies
79. Preferential chromosome 11q and/or 17q aberrations in short-term cultures of metastatic melanoma resections from the brain
80. Isolation and characterization of spontaneous wheat germ agglutinin-resistant human melanoma mutants displaying remarkably different metastatic profiles in nude mice
81. Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production
82. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor
83. Identification, purification and characterization of truncated forms of the human nerve growth factor receptor
84. Properties of the nerve growth factor receptor. Relationship between receptor structure and affinity
85. Purification and some properties of lung-derived growth factor that differentially stimulates the growth of tumor cells metastatic to the lung
86. Lung-derived growth factor for lung-metastasizing tumor cells: identification as a transferrin
87. Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials
88. Transferrin and the growth-promoting effect of nerves
89. Paracrine growth factors for metastatic breast cancer cells: cloning of three new transferrin-like growth factor cDNAs that may be involved in the growth stimulation of breast cancer cells at secondary sites
90. Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis
91. Cellular distribution of transferrin, ferritin and iron in normal and aged human brains
92. Immunocytochemical localisation of transferrin in the human brain
93. Effects of interleukin-1 beta and tumor necrosis factor-alpha on the expression of glial fibrillary acidic protein and transferrin in cultured astrocytes
94. Transferrin receptors in injured brain
95. Transforming growth factor-betas inhibit mitogen-stimulated proliferation of astrocytes
96. The proliferation of mature oligodendrocytes in vitro is stimulated by basic fibroblast growth factor and inhibited by oligodendrocyte-type 2 astrocyte precursors
97. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological
98. Differentiation driven by granulocyte-macrophage colony-stimulating factor endows microglia with interferon-gamma-independent antigen presentation function
99. Immunoelectron microscopic localization of basic FGF in neuroglias and neurons of the trigeminal mesencephalic and motor nuclei
100. Localization of basic fibroblast growth factor and vascular endothelial growth factor in human glial neoplasms
101. Production of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes
102. Transforming growth factor-beta 1 stimulates expression of nerve growth factor in the rat CNS
103. Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation
104. Critical factors regulating site-specific brain metastasis of murine melanomas
105. Stimulation of biosynthesis of nerve growth factor by acidic fibroblast growth factor in cultured mouse astrocytes
106. Fibroblast growth factors stimulate nerve growth factor synthesis and secretion by astrocytes
107. Cooperative regulation of nerve growth factor synthesis and secretion in fibroblasts and astrocytes by fibroblast growth factor and other cytokines
108. Cytokine regulation of nerve growth factor-mediated cholinergic neurotrophic activity synthesized by astrocytes and fibroblasts
109. Establishment of an astrocyte progenitor cell line: induction of glial fibrillary acidic protein and fibronectin by transforming growth factor-beta 1
110. Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression
111. TNF alpha induces IL-6 production by astrocytes but not by microglia
112. Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes
113. Effect of ciliary neurotrophic factor (CNTF) on motoneuron survival
114. The nerve growth factor 35 years later
115. Astrocyte responses to CNS injury
116. Astrocyte heterogeneity
117. Coupling among identified cells in mammalian nervous system cultures
118. Physiological aspects of astrocyte swelling
119. Electron microscopy of the blood brain barrier
120. Vascular permeability and cerebral oedema in experimental brain tumors
121. Resolution of vasogenic brain edema (VBE)
122. Expression of class II major histocompatibility antigens on reactive astrocytes and endothelial cells within gliosis surrounding metastases and abscesses
123. Receptor tyrosine kinase expression in astrocytic lesions: similar features in gliosis and glioma
124. Bidirectional passage of peptides across the blood brain barrier
125. The cloning of a family of genes that encode the melanocortin receptors
126. Experimental metastasis and differentiation of murine melanoma cells: actions and interactions of factors affecting different intracellular signaling pathways
127. Homologous and heterologous regulation of a-melanocyte stimulating hormone receptors in human and mouse melanoma cell lines
128. Differentiation and the tumorigenic and metastatic phenotype of murine melanoma cells
129. Alpha-MSH peptides inhibit acute inflammation induced in mice by rIL-1 beta, rIL-6, rTNF-alpha and endogenous pyrogen but not that caused by LTB-4, PAF and rIL-8
130. Central neurogenic anti-inflammatory action of alpha-MSH: modulation of peripheral inflammation induced by cytokines and other mediators of inflammation